Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer with poor
prognosis. Surgery, chemotherapy, and radiofrequency ablation are three conventional …

In the last decade, immunotherapy has revolutionized the treatment landscape of several
hematological and solid malignancies, reporting unprecedented response rates …

Cell membrane-based nanovaccines have demonstrated attractive features due to their
inherently multiantigenic nature and ability to be formulated with adjuvants. Here, we report …

Prostate cancer (PCa) is the most common cancer in men. The androgen receptor (AR) has
a pivotal role in the pathogenesis and progression of PCa. Many therapies targeting AR …

Cancer treatment is presently one of the most important challenges in medical science.
Surgery, chemotherapy, radiotherapy, or combining these methods is used to eliminate the …

Prostate cancer is the most commonly diagnosed cancer in men worldwide, making up 21%
of all cancer cases. With 345,000 deaths per year owing to the disease, there is an urgent …

Hedyotis diffusa Willd (HDW) is one of the most well-known herbs used in the treatment of
prostate cancer. However, the potential mechanisms of its anti-tumor effects have not been …

Prophylactic vaccination against infectious diseases is one of the most successful public
health measures of our lifetime. More recently, therapeutic vaccination against established …

Prostate cancer is the most common cancer among men and the second leading cause of
cancer-related death. For patients who develop metastatic disease, tissue-based and …

Importance Sipuleucel-T was the first therapeutic cancer vaccine approved by the US Food
and Drug Administration (FDA) in 2010. Although almost a decade has passed since its …